TrialInvestigational new drugs2014

A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.

Meng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.